- Mar 29, 2016

Children’s Hospital Los Angeles to Initiate Clinical Trial for Kids with Treatment-Resistant Leukemi

The Children’s Center for Cancer and Blood Diseases (CCCBD) at Children’s Hospital Los Angeles is one of the first sites in the world to offer a promising new investigational therapy to treat pediatric acute lymphoblastic leukemia (ALL).

Fusion oncoprotein forces cell fates toward rhabdomyosarcoma

“DNA loops” in pediatric brain tumors double relapse risk

Radiation from a childhood CT scan increases the risk of developing cancer

Childhood Leukemia Linked to Pesticides Used in Vineyards

FDA Gives Priority Review to Tovorafenib in Pediatric Low-Grade Glioma

NIH researchers develop approach that could help supercharge T-cell therapies against solid tumors

Cranial Radiotherapy Predisposes Pediatric Cancer Survivors to Hypothyroidism

Examining outcomes in children with Down syndrome and acute lymphoblastic leukemia

Impact of childhood and adolescence cancer on family caregivers

Collaborative study identifies potential targets to treat the most common childhood liver cancer

Recent Posts

Children’s Hospital Los Angeles to Initiate Clinical Trial for Kids with Treatment-Resistant Leukemi

Archive

Search By Tags